FDR Stock Analysis: Fluidra | MC
Leisure | MC, Spain | Market Cap: 3.253m EUR | 12M Return: -22.9% | ES0137650018 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.26M
EPS Trend: 95.8%
Qual. Beats: 0
Rev. Trend: 95.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Fluidra is a Spanish-based global manufacturer and distributor specializing in equipment, accessories, and machinery for swimming pools, water treatment, and fluid handling. The company operates primarily within the industrial machinery and supplies sector, serving both residential and commercial end-markets worldwide through a portfolio spanning basic pool equipment, specialized products, water purification systems, and fluid control components.
The companys product offering is highly diversified, covering pumps, filters, heaters, robotic cleaners, pool covers, disinfection systems (such as salt chlorinators and UV equipment), chemical products, and irrigation accessories. It also addresses public and commercial aquatic facilities-including hotels, water parks, municipal pools, and fountains-as well as wellness applications like saunas and steam baths. This breadth reflects a business model built around serving the full lifecycle of pool and water infrastructure, from equipment supply to ongoing water-quality maintenance.
Fluidra sells through a multi-brand strategy, with notable names including AstralPool, Zodiac, Jandy, Polaris, Gre, Cepex, and Certikin, allowing it to address different price points and regional preferences. Founded in 1969 and headquartered in Sant Cugat del Vallès, Spain, the company was originally known as Aquaria de Inv. Corp., S.L., before adopting the Fluidra name in September 2007.
- North America pool equipment demand drives segment revenue growth
- Housing market slowdown pressures new pool installation orders
- Raw material and freight costs pressure gross margins
| Net Income: 166.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.07 > 1.0 |
| NWC/Revenue: 16.68% < 20% (prev 18.15%; Δ -1.47% < -1%) |
| CFO/TA 0.09 > 3% & CFO 342.6m > Net Income 166.4m |
| Net Debt (1.30b) to EBITDA (840.1m): 1.55 < 3 |
| Current Ratio: 1.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (189.9m) vs 12m ago 0.00% < -2% |
| Gross Margin: 29.01% > 18% (prev 51.94%; Δ -22.93% > 0.5%) |
| Asset Turnover: 60.32% > 50% (prev 60.69%; Δ -0.37% > 0%) |
| Interest Coverage Ratio: 12.05 > 6 (EBIT TTM 677.7m / Interest Expense TTM 56.2m) |
| A: 0.10 (Total Current Assets 1.12b - Total Current Liabilities 746.3m) / Total Assets 3.76b |
| B: 0.08 (Retained Earnings 294.4m / Total Assets 3.76b) |
| C: 0.18 (EBIT TTM 677.7m / Avg Total Assets 3.67b) |
| D: 0.77 (Book Value of Equity 1.63b / Total Liabilities 2.12b) |
| Altman-Z'' = 2.95 = A |
| DSRI: 1.02 (Receivables 469.8m/451.2m, Revenue 2.22b/2.18b) |
| GMI: 1.79 (GM 51.94% / 29.01%) |
| AQI: 1.00 (AQ_t 0.60 / AQ_t-1 0.60) |
| SGI: 1.02 (Revenue 2.22b / 2.18b) |
| TATA: -0.05 (NI 166.4m - CFO 342.6m) / TA 3.76b) |
| Beneish M = -2.28 (Cap -4..+1) = BBB |
As of October 17, 2026, the stock is trading at EUR 17.69 with a total of 360,929 shares traded. Over the past week, the price has changed by +3.15%, over one month by -0.84%, over three months by -2.75% and over the past year by -22.85%.
Current recommended Stop Loss: 17.20 (which is 2.8% or 1.3 ATR below the current price).
Fluidra has no consensus analysts rating.
P/E Trailing = 19.6818
P/E Forward = 9.7371
P/S = 1.4184
P/B = 2.0686
P/EG = 0.6412
Revenue TTM = 2.22b EUR
EBIT TTM = 677.7m EUR
EBITDA TTM = 840.1m EUR
Long Term Debt = 1.05b EUR (from longTermDebt, last quarter)
Short Term Debt = 70.2m EUR (from shortTermDebt, last quarter)
Debt = 1.45b EUR (from shortLongTermDebtTotal, last quarter) + Leases 192.4m
Net Debt = 1.30b EUR (calculated: Debt 1.45b - CCE 141.5m)
Enterprise Value = 4.56b EUR (3.25b + Debt 1.45b - CCE 141.5m)
Interest Coverage Ratio = 12.05 (Ebit TTM 677.7m / Interest Expense TTM 56.2m)
EV/FCF = 15.09x (Enterprise Value 4.56b / FCF TTM 302.1m)
FCF Yield = 6.63% (FCF TTM 302.1m / Enterprise Value 4.56b)
FCF Margin = 13.64% (FCF TTM 302.1m / Revenue TTM 2.22b)
Net Margin = 7.51% (Net Income TTM 166.4m / Revenue TTM 2.22b)
Gross Margin = 29.01% ((Revenue TTM 2.22b - Cost of Revenue TTM 1.57b) / Revenue TTM)
Gross Margin QoQ = 50.19% (prev 50.18%)
Tobins Q-Ratio = 1.21 (Enterprise Value 4.56b / Total Assets 3.76b)
Interest Expense / Debt = 3.89% (Interest Expense 56.2m / Debt 1.45b)
Taxrate = 26.35% (60.5m / 229.6m)
NOPAT = 499.1m (EBIT 677.7m * (1 - 26.35%))
Current Ratio = 1.50 (Total Current Assets 1.12b / Total Current Liabilities 746.3m)
Debt / Equity = 0.89 (Debt 1.45b / totalStockholderEquity, last quarter 1.63b)
Debt / EBITDA = 1.55 (Net Debt 1.30b / EBITDA 840.1m)
Debt / FCF = 4.32 (Net Debt 1.30b / FCF TTM 302.1m)
Total Stockholder Equity = 1.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.53% (Net Income 166.4m / Total Assets 3.76b)
RoE = 10.31% (Net Income TTM 166.4m / Total Stockholder Equity 1.61b)
RoCE = 25.49% (EBIT 677.7m / Capital Employed (Equity 1.61b + L.T.Debt 1.05b))
RoIC = 16.80% (NOPAT 499.1m / Invested Capital 2.97b)
WACC = 6.70% (E(3.25b)/V(4.70b) * Re(8.40%) + D(1.45b)/V(4.70b) * Rd(3.89%) * (1-Tc(0.26)))
Discount Rate = 8.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 87.24 | Cagr: 0.01%
[DCF] Terminal Value 77.97% ; FCFF base≈252.5m ; Y1≈289.5m ; Y5≈426.0m
[DCF] Fair Price = 27.19 (EV 6.41b - Net Debt 1.30b = Equity 5.11b / Shares 187.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.78 | EPS CAGR: 12.21% | SUE: 0.0 | # QB: 0
Revenue Correlation: 95.01 | Revenue CAGR: 2.60% | SUE: 0.14 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.24 | Chg30d=-15.29% | Revisions=-25% | Analysts=2
EPS current Year (2026-12-31): EPS=1.33 | Chg30d=+0.66% | Revisions=-17% | GrowthEPS=+2.2% | GrowthRev=+3.8%
EPS next Year (2027-12-31): EPS=1.55 | Chg30d=+0.89% | Revisions=-17% | GrowthEPS=+16.3% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: -30% (up=2, down=5)